Page 9 - Haematologica Vol. 109 - July 2024

2346 Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
S. Blum et al.
https://doi.org/10.3324/haematol.2023.284858
2351 High annualized bleeding rates in pediatric patients with inherited platelet function disorders S. Saini et al.
https://doi.org/10.3324/haematol.2024.284996
2355 Efficacy and safety of daratumumab plus bortezomib and dexamethasone in newly diagnosed Mayo 2004 stage IIIA or IIIB light-chain amyloidosis: a prospective phase II study
K. Shen et al.
https://doi.org/10.3324/haematol.2024.285145
2359 Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up
E.J. Pulczynski et al.
https://doi.org/10.3324/haematol.2024.285207
Case Reports & Case Series
Errata Corrige
2364 Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin
V. Genoud et al.
https://doi.org/10.3324/haematol.2023.284318
2368 Phenomenon of tumor flare with talquetamab in a patient with extramedullary myeloma M. Forsberg et al.
https://doi.org/10.3324/haematol.2023.284436
2372 Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising virus-specific and anti-myeloma T-cell responses
M.H. Kocoglu et al.
https://doi.org/10.3324/haematol.2023.284793
2378 Erratum to: Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies
D.W. Woolston et al. https://doi.org/10.3324/haematol.2024.285151
2379 Erratum to: Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard risk acute myeloid leukemia
M. Maurer-Granofszky et al.
https://doi.org/10.3324/haematol.2024.285153
Haematologica | 109 July 2024
V